Axogen (STU:LT3) Float Percentage Of Total Shares Outstanding: 86.35% (As of Jul. 13, 2026)


STU:LT3 Axogen Inc STU:LT3
70 GF Score
Price €35.45
GF Value €13.23
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Axogen Float Percentage Of Total Shares Outstanding?

Axogen STU:LT3 -7.00% 70 Float Percentage Of Total Shares Outstanding is 86.35% as of Jul. 13, 2026. GuruFocus rates STU:LT3 with a GF Score™ of 70/100 and a GF Value™ of €13.23 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Axogen's float shares is 45.92 Mil. Axogen's total shares outstanding is 53.18 Mil. Axogen's float percentage of total shares outstanding is 86.35%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Axogen's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Axogen's Institutional Ownership is 46.89%.

STU:LT3
70GF Score
Axogen Inc STU:LT3
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Axogen Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Axogen's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=45.92/53.18
=86.35%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 86.35% mean?
Axogen (STU:LT3) has a Float Percentage Of Total Shares Outstanding of 86.35% as of Jul. 13, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Axogen and its competitors.
Is Axogen's Float Percentage Of Total Shares Outstanding too high?
Axogen's current Float Percentage Of Total Shares Outstanding is 86.35%. Overall, Axogen has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Axogen's Float Percentage Of Total Shares Outstanding compare to TMDX and BFLY?
Axogen's Float Percentage Of Total Shares Outstanding of 86.35% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Axogen and its competitors. Axogen's current Float Percentage Of Total Shares Outstanding is 86.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Axogen stock overvalued right now?
Based on GuruFocus' analysis, Axogen (STU:LT3) is currently considered Significantly Overvalued. The stock's GF Value™ is €13.23, compared to a current price of €35.45 — trading 168% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 86.35%. Axogen's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Axogen (STU:LT3), the current Float Percentage Of Total Shares Outstanding is 86.35% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Axogen (STU:LT3) Overvalued in 2026?

Based on GuruFocus' analysis, Axogen stock appears to be overvalued. The current stock price of €35.45 is trading 168% above its estimated GF Value™ of €13.23. GuruFocus considers Axogen to be Significantly Overvalued.

Key valuation signals for STU:LT3:

  • Float Percentage Of Total Shares Outstanding: 86.35%
  • GF Value™: €13.23 vs. price of €35.45 (168% above fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the STU:LT3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Axogen Business Description

Other Exchanges AXGN:USA0HKD:UK
Address 13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
70GF Score

Get the complete analysis for STU:LT3

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€35.45
Price
€13.23
GF Value